Vir Biotechnology, Inc.
VIR
$9.26
-$0.22-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.32% | -81.53% | -78.88% | -76.73% | -16.61% |
| Total Other Revenue | 44.75% | -- | -- | -- | -- |
| Total Revenue | -7.61% | -78.55% | -75.91% | -73.79% | -13.90% |
| Cost of Revenue | -9.33% | -7.08% | 12.78% | 0.55% | -13.34% |
| Gross Profit | 9.63% | -6.09% | -31.37% | -14.05% | 13.24% |
| SG&A Expenses | -22.65% | -28.75% | -33.66% | -34.96% | -31.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.88% | -11.61% | 1.34% | -7.98% | -17.60% |
| Operating Income | 12.46% | 2.21% | -12.95% | -0.71% | 18.08% |
| Income Before Tax | 16.31% | 7.38% | -11.72% | -5.28% | 16.73% |
| Income Tax Expenses | 118.95% | 104.59% | 103.00% | 86.71% | 91.24% |
| Earnings from Continuing Operations | 16.09% | 6.32% | -13.91% | -7.08% | 15.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.09% | 6.32% | -13.91% | -7.08% | 15.14% |
| EBIT | 12.46% | 2.21% | -12.95% | -0.71% | 18.08% |
| EBITDA | 12.26% | 1.46% | -14.64% | -1.66% | 17.87% |
| EPS Basic | 17.32% | 7.74% | -12.10% | -5.24% | 16.56% |
| Normalized Basic EPS | 9.37% | -1.89% | -19.63% | -3.80% | 20.40% |
| EPS Diluted | 17.32% | 7.84% | -11.97% | -5.12% | 16.64% |
| Normalized Diluted EPS | 9.37% | -1.89% | -19.63% | -3.80% | 20.40% |
| Average Basic Shares Outstanding | 1.67% | 1.64% | 1.66% | 1.66% | 1.58% |
| Average Diluted Shares Outstanding | 1.67% | 1.64% | 1.66% | 1.66% | 1.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |